Loading...

Bayer AG
XETRA:BAYN

Watchlist Manager
Bayer AG Logo
Bayer AG
XETRA:BAYN
Watchlist
Price: 55.55 EUR -0.7% Market Closed
Updated: Mar 25, 2023

Profitability Summary

47/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

47/100
Profitability
Score
47/100
Profitability
Score

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Bayer AG

Revenue
50.7B EUR
Cost of Revenue
-19.9B EUR
Gross Profit
30.9B EUR
Operating Expenses
-23.9B EUR
Operating Income
7B EUR
Other Expenses
-2.9B EUR
Net Income
4.2B EUR

Margins Comparison
Bayer AG Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
DE
Bayer AG
XETRA:BAYN
54.6B EUR
61%
14%
8%
ZA
Aspen Pharmacare Holdings Ltd
JSE:APN
8T Zac
47%
21%
15%
US
Johnson & Johnson
NYSE:JNJ
476B USD
67%
28%
19%
DK
Novo Nordisk A/S
NYSE:NVO
348B USD
84%
42%
31%
US
Eli Lilly and Co
NYSE:LLY
319B USD
77%
29%
22%
US
Merck & Co Inc
NYSE:MRK
266B USD
71%
34%
24%
US
Pfizer Inc
NYSE:PFE
227B USD
66%
38%
31%
CH
Roche Holding AG
SIX:ROG
206B CHF
69%
31%
23%
UK
AstraZeneca PLC
LSE:AZN
172B GBP
80%
19%
7%
CH
Novartis AG
SIX:NOVN
162B CHF
71%
25%
13%
US
Bristol-Myers Squibb Co
NYSE:BMY
140B USD
78%
25%
14%
Country DE
Market Cap 54.6B EUR
Gross Margin
61%
Operating Margin
14%
Net Margin
8%
Country ZA
Market Cap 8T Zac
Gross Margin
47%
Operating Margin
21%
Net Margin
15%
Country US
Market Cap 476B USD
Gross Margin
67%
Operating Margin
28%
Net Margin
19%
Country DK
Market Cap 348B USD
Gross Margin
84%
Operating Margin
42%
Net Margin
31%
Country US
Market Cap 319B USD
Gross Margin
77%
Operating Margin
29%
Net Margin
22%
Country US
Market Cap 266B USD
Gross Margin
71%
Operating Margin
34%
Net Margin
24%
Country US
Market Cap 227B USD
Gross Margin
66%
Operating Margin
38%
Net Margin
31%
Country CH
Market Cap 206B CHF
Gross Margin
69%
Operating Margin
31%
Net Margin
23%
Country UK
Market Cap 172B GBP
Gross Margin
80%
Operating Margin
19%
Net Margin
7%
Country CH
Market Cap 162B CHF
Gross Margin
71%
Operating Margin
25%
Net Margin
13%
Country US
Market Cap 140B USD
Gross Margin
78%
Operating Margin
25%
Net Margin
14%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Bayer AG Competitors

Country Company Market Cap ROE ROA ROCE ROIC
DE
Bayer AG
XETRA:BAYN
54.6B EUR
12%
3%
8%
6%
ZA
Aspen Pharmacare Holdings Ltd
JSE:APN
8T Zac
8%
5%
8%
6%
US
Johnson & Johnson
NYSE:JNJ
476B USD
24%
10%
20%
15%
DK
Novo Nordisk A/S
NYSE:NVO
348B USD
72%
25%
69%
32%
US
Eli Lilly and Co
NYSE:LLY
319B USD
64%
13%
25%
17%
US
Merck & Co Inc
NYSE:MRK
266B USD
35%
14%
24%
19%
US
Pfizer Inc
NYSE:PFE
227B USD
36%
17%
26%
22%
CH
Roche Holding AG
SIX:ROG
206B CHF
47%
17%
33%
22%
UK
AstraZeneca PLC
LSE:AZN
172B GBP
9%
3%
11%
15%
CH
Novartis AG
SIX:NOVN
162B CHF
11%
6%
14%
11%
US
Bristol-Myers Squibb Co
NYSE:BMY
140B USD
19%
6%
14%
11%
Country DE
Market Cap 54.6B EUR
ROE
12%
ROA
3%
ROCE
8%
ROIC
6%
Country ZA
Market Cap 8T Zac
ROE
8%
ROA
5%
ROCE
8%
ROIC
6%
Country US
Market Cap 476B USD
ROE
24%
ROA
10%
ROCE
20%
ROIC
15%
Country DK
Market Cap 348B USD
ROE
72%
ROA
25%
ROCE
69%
ROIC
32%
Country US
Market Cap 319B USD
ROE
64%
ROA
13%
ROCE
25%
ROIC
17%
Country US
Market Cap 266B USD
ROE
35%
ROA
14%
ROCE
24%
ROIC
19%
Country US
Market Cap 227B USD
ROE
36%
ROA
17%
ROCE
26%
ROIC
22%
Country CH
Market Cap 206B CHF
ROE
47%
ROA
17%
ROCE
33%
ROIC
22%
Country UK
Market Cap 172B GBP
ROE
9%
ROA
3%
ROCE
11%
ROIC
15%
Country CH
Market Cap 162B CHF
ROE
11%
ROA
6%
ROCE
14%
ROIC
11%
Country US
Market Cap 140B USD
ROE
19%
ROA
6%
ROCE
14%
ROIC
11%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Similar Stocks